| Term 
 
        | MOA of Actonel (risedronate)? |  | Definition 
 
        | bisphosphonates: inhibit formatn and activities of osteoclasts via inhibition of certain compds/proteins |  | 
        |  | 
        
        | Term 
 
        | MOA of Didronel (etidronate)? |  | Definition 
 
        | bisphosphonates: inhibit formatn and activities of osteoclasts via inhibition of certain compds/proteins |  | 
        |  | 
        
        | Term 
 
        | MOA of Fosamax (alendronate)? |  | Definition 
 
        | bisphosphonates: inhibit formatn and activities of osteoclasts via inhibition of certain compds/proteins |  | 
        |  | 
        
        | Term 
 
        | MOA of Aredia (pamidronate)? |  | Definition 
 
        | bisphosphonates: inhibit formatn and activities of osteoclasts via inhibition of certain compds/proteins |  | 
        |  | 
        
        | Term 
 
        | MOA of Boniva (ibandronate)? |  | Definition 
 
        | bisphosphonates: inhibit formatn and activities of osteoclasts via inhibition of certain compds/proteins |  | 
        |  | 
        
        | Term 
 
        | MOA of Skelid (tiludronate)? |  | Definition 
 
        | bisphosphonates: inhibit formatn and activities of osteoclasts via inhibition of certain compds/proteins |  | 
        |  | 
        
        | Term 
 
        | MOA of Bonefos (clodronate)? |  | Definition 
 
        | bisphosphonates: inhibit formatn and activities of osteoclasts via inhibition of certain compds/proteins |  | 
        |  | 
        
        | Term 
 
        | MOA of Reclast (zoledronic acid)? |  | Definition 
 
        | bisphosphonates: inhibit formatn and activities of osteoclasts via inhibition of certain compds/proteins |  | 
        |  | 
        
        | Term 
 
        | MOA of Zometa (zoledronic acid)? |  | Definition 
 
        | bisphosphonates: inhibit formatn and activities of osteoclasts via inhibition of certain compds/proteins |  | 
        |  | 
        
        | Term 
 
        | MOA of Evista (raloxifene)? |  | Definition 
 
        | SERMs (selective estrogens receptors modulators): ↓resorption, ↑bone building |  | 
        |  | 
        
        | Term 
 
        | MOA of Cibacalcin (calcitonin human)? |  | Definition 
 
        | ↓resorption, ↓(total # of osteoclasts) |  | 
        |  | 
        
        | Term 
 
        | MOA of Miacalcin (calcitonin salmon)? |  | Definition 
 
        | ↓resorption, ↓(total # of osteoclasts) |  | 
        |  | 
        
        | Term 
 
        | MOA of Fortical  (calcitonin salmon)? |  | Definition 
 
        | ↓resorption, ↓(total # of osteoclasts) |  | 
        |  | 
        
        | Term 
 
        | MOA of Calcimar (calcitonin salmon)? |  | Definition 
 
        | ↓resorption, ↓(total # of osteoclasts) |  | 
        |  | 
        
        | Term 
 
        | MOA of Premarin (estrogens conjugated)? |  | Definition 
 
        | ↑Estrogen→↑OPG(OsteoProteGerin: inhibitor of RANKL)→↓RANKL→↓Resorption |  | 
        |  | 
        
        | Term 
 
        | MOA of Cenestin (estrogens conjugated, A)? |  | Definition 
 
        | ↑Estrogen→↑OPG(OsteoProteGerin: inhibitor of RANKL)→↓RANKL→↓Resorption |  | 
        |  | 
        
        | Term 
 
        | MOA of Enjuvia (estrogens conjugated, B)? |  | Definition 
 
        | ↑Estrogen→↑OPG(OsteoProteGerin: inhibitor of RANKL)→↓RANKL→↓Resorption |  | 
        |  | 
        
        | Term 
 
        | MOA of Menest (esterified estrogen)? |  | Definition 
 
        | ↑Estrogen→↑OPG(OsteoProteGerin: inhibitor of RANKL)→↓RANKL→↓Resorption |  | 
        |  | 
        
        | Term 
 
        | MOA of Prempro (premarin+medroxyprogesterone(MDPG))? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | MOA of Premphase (premarin+medroxyprogesterone(MDPG))? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | MOA of Testred (methyltestosterone)? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | MOA of Forteo (teriparatide)? |  | Definition 
 
        | intermitting, bolus dose of PTH: ↑osteoblast |  | 
        |  | 
        
        | Term 
 
        | MOA of Xgeva (denosumab)? |  | Definition 
 
        | Monoclonal antibodies (Mabs): RANKL inhibition |  | 
        |  | 
        
        | Term 
 
        | MOA of Prolia (denosumab)? |  | Definition 
 
        | Monoclonal antibodies (Mabs): RANKL inhibition |  | 
        |  | 
        
        | Term 
 
        | MOA of Delta-D (cholecalciferol)? |  | Definition 
 
        | Vitamin D3 derivative: after cleavage of C9 and C10 bond |  | 
        |  | 
        
        | Term 
 
        | MOA of Calderol (calcidiol)? |  | Definition 
 
        | Vitamin D3 derivative: after hydroxylation of C25 in the liver |  | 
        |  | 
        
        | Term 
 
        | MOA of Rocaltrol (calcitriol)? |  | Definition 
 
        | Vitamin D3 active: after dual hydroxylation of C25, and C1 (in the kidney) |  | 
        |  | 
        
        | Term 
 
        | MOA of Calcijex (calcitriol)? |  | Definition 
 
        | Vitamin D3 active: after dual hydroxylation of C25 (in the liver), and C1 (in the kidney) |  | 
        |  | 
        
        | Term 
 
        | MOA of Dovonex (calcipotriene)? |  | Definition 
 
        | Vitamin D3 analog of calcitriol |  | 
        |  | 
        
        | Term 
 
        | MOA of Hectorol (doxercalciferol)? |  | Definition 
 
        | Vitamin D2 analog: only need to be hydroxylated in the liver |  | 
        |  | 
        
        | Term 
 
        | MOA of Zemplar (paricalcitol)? |  | Definition 
 
        | Vitamin D2 analog: already activated at C1 and C25 |  | 
        |  | 
        
        | Term 
 
        | MOA of Calciferol (ergocalciferol)? |  | Definition 
 
        | Vitamin D2 analog: produced from pro-vitamin D2 - ergosterol (after UV light cleavage) |  | 
        |  |